The Remote Site Where the Video Camera Kept Running

The technician's conduct is the central violation. A remote site operates on the premise that a pharmacist is available in real time: the pharmacist performs prospective drug review, final verification before release, and patient counseling. Those are nondelegable professional functions. A technician may receive and enter the prescription, prepare and label it, manage inventory, process the sale, and perform the mechanical steps that do not require professional judgment. A technician may never release a prescription to a patient when no supervising pharmacist is available, and the fact that a video link is powered on is irrelevant - availability means a pharmacist who is actually able to review, verify, and counsel.

When supervision lapses, the site must stop dispensing: lock or suspend the release function, hold prepared prescriptions, and document the time the pharmacist became unavailable and the time supervision resumed. The technician should have called the hub. The Board inspector at 12:30 will be looking at whether the site has a written procedure for pharmacist unavailability, whether release is technically blocked, and whether the site's records can identify which pharmacist verified each prescription. The corrective action should be a system control, not a reminder to staff.

It is a Schedule II prescription, so the full controlled substance discipline applies even though the pharmacist is 140 miles away. The prescription must be valid on its face - prescriber, DEA number, date, drug, strength, quantity, directions, and no refills - and the pharmacist must verify the patient, check the prescription monitoring program, and confirm there is no pattern of early fills or multiple prescribers. If anything is doubtful, the pharmacist resolves it before release, not after.

The pharmacist verifies the prepared prescription remotely and counsels the patient by two-way audio and video, with an offer of a private consultation and a documented note of what was discussed. The label must identify the dispensing site and the verifying pharmacist, and the patient information leaflet must accompany the product. If North Dakota's remote-site rules or the site's approval conditions limit which controlled substances may be dispensed at remote sites, or require additional safeguards, those conditions control and the prescription is referred to the hub. The technician may hand the completed prescription to the patient only after the pharmacist's verification is recorded. Any refusal or unresolved red flag follows the same documentation standard as at the hub.

The technician cannot administer the vaccine. Immunization authority in North Dakota belongs to licensed pharmacists and other authorized immunizers; a registered technician at a remote site is not one of them, and the technician cannot create authority by having a video link open. The correct response is to schedule the patient for a time when a qualified immunizer is available at the site or refer the patient to the hub or a local clinic, and document the referral. If vaccine administration at remote sites is permitted under Board-approved protocols, the protocol must be followed exactly and the immunizer must be physically present and prepared to manage an adverse reaction.

The pharmacist-in-charge carries the responsibility for the site's compliance. The 45-minute gap is a record that the site dispensed without supervision, which supports findings around the site's procedures, its system controls, and the adequacy of pharmacist coverage. Expect the inspector to request the prescription records released during the gap, the supervision log, and the site's written policy. The PIC should self-report the gap to the Board, produce a corrective action plan that includes a hard system block on release without an available pharmacist, back-up pharmacist coverage, and staff retraining with signatures, and document completion. Silence, or an explanation that "the video was on," will not be accepted.